Review



real world inflammatory bowel disease (ibd) disease specific programme (dsp)  (Adelphi Technology Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Adelphi Technology Inc real world inflammatory bowel disease (ibd) disease specific programme (dsp)
    Real World Inflammatory Bowel Disease (Ibd) Disease Specific Programme (Dsp), supplied by Adelphi Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inflammatory+bowel-disease+specific+programme/real+world+ibd+disease+specific+programme/pm37957522-176-5-5
    Average 90 stars, based on 1 article reviews
    real world inflammatory bowel disease (ibd) disease specific programme (dsp) - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe
    Article Snippet: Data from the 2017 Adelphi Inflammatory Bowel-Disease Specific Programme (IBD-DSP) were used.



    Similar Products

    real world inflammatory bowel disease (ibd) disease specific programme (dsp)  (Adelphi Technology Inc)
    90
    Adelphi Technology Inc real world inflammatory bowel disease (ibd) disease specific programme (dsp)
    Real World Inflammatory Bowel Disease (Ibd) Disease Specific Programme (Dsp), supplied by Adelphi Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inflammatory+bowel-disease+specific+programme/real+world+ibd+disease+specific+programme/pm37957522-176-5-5
    Average 90 stars, based on 1 article reviews
    real world inflammatory bowel disease (ibd) disease specific programme (dsp) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    inflammatory bowel disease (ibd) disease specific programme (dsp) survey  (Adelphi Technology Inc)
    90
    Adelphi Technology Inc inflammatory bowel disease (ibd) disease specific programme (dsp) survey
    Logistic regression analyses for rectal urgency in patients with ulcerative colitis. ASA = aminosalicylic acid; BMI = body mass index; CI = confidence interval; SIBDQ = Short <t>Inflammatory</t> <t>Bowel</t> <t>Disease</t> Questionnaire; UC = ulcerative colitis; OR = odds ratio; Odds ratios were computed in the regressions and, for categorical outcomes, are in comparison to the baseline reference categories: No fatigue, no abdominal pain, stool frequency (normal number of stools), no blood seen, medication use (not 5-ASA, not corticosteroid, not immunomodulators, not biologics/biosimilars).
    Inflammatory Bowel Disease (Ibd) Disease Specific Programme (Dsp) Survey, supplied by Adelphi Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inflammatory+bowel-disease+specific+programme/inflammatory+bowel+disease+specific+programme/pmc10622170-260-16-15
    Average 90 stars, based on 1 article reviews
    inflammatory bowel disease (ibd) disease specific programme (dsp) survey - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    inflammatory bowel disease-specific programme  (Adelphi Technology Inc)
    90
    Adelphi Technology Inc inflammatory bowel disease-specific programme
    Logistic regression analyses for rectal urgency in patients with ulcerative colitis. ASA = aminosalicylic acid; BMI = body mass index; CI = confidence interval; SIBDQ = Short <t>Inflammatory</t> <t>Bowel</t> <t>Disease</t> Questionnaire; UC = ulcerative colitis; OR = odds ratio; Odds ratios were computed in the regressions and, for categorical outcomes, are in comparison to the baseline reference categories: No fatigue, no abdominal pain, stool frequency (normal number of stools), no blood seen, medication use (not 5-ASA, not corticosteroid, not immunomodulators, not biologics/biosimilars).
    Inflammatory Bowel Disease Specific Programme, supplied by Adelphi Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inflammatory+bowel-disease+specific+programme/inflammatory+bowel+disease+specific+programme/pm37351647-29-13-14
    Average 90 stars, based on 1 article reviews
    inflammatory bowel disease-specific programme - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    disease specific programme™ inflammatory bowel disease  (Adelphi Technology Inc)
    90
    Adelphi Technology Inc disease specific programme™ inflammatory bowel disease
    Logistic regression analyses for rectal urgency in patients with ulcerative colitis. ASA = aminosalicylic acid; BMI = body mass index; CI = confidence interval; SIBDQ = Short <t>Inflammatory</t> <t>Bowel</t> <t>Disease</t> Questionnaire; UC = ulcerative colitis; OR = odds ratio; Odds ratios were computed in the regressions and, for categorical outcomes, are in comparison to the baseline reference categories: No fatigue, no abdominal pain, stool frequency (normal number of stools), no blood seen, medication use (not 5-ASA, not corticosteroid, not immunomodulators, not biologics/biosimilars).
    Disease Specific Programme™ Inflammatory Bowel Disease, supplied by Adelphi Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inflammatory+bowel-disease+specific+programme/inflammatory+bowel+disease+specific+programme/pmc08194832-2-22-21
    Average 90 stars, based on 1 article reviews
    disease specific programme™ inflammatory bowel disease - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    inflammatory bowel disease specific programme  (Adelphi Technology Inc)
    90
    Adelphi Technology Inc inflammatory bowel disease specific programme
    Logistic regression analyses for rectal urgency in patients with ulcerative colitis. ASA = aminosalicylic acid; BMI = body mass index; CI = confidence interval; SIBDQ = Short <t>Inflammatory</t> <t>Bowel</t> <t>Disease</t> Questionnaire; UC = ulcerative colitis; OR = odds ratio; Odds ratios were computed in the regressions and, for categorical outcomes, are in comparison to the baseline reference categories: No fatigue, no abdominal pain, stool frequency (normal number of stools), no blood seen, medication use (not 5-ASA, not corticosteroid, not immunomodulators, not biologics/biosimilars).
    Inflammatory Bowel Disease Specific Programme, supplied by Adelphi Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inflammatory+bowel-disease+specific+programme/inflammatory+bowel+disease+specific+programme/pmc06975026-265-8-9
    Average 90 stars, based on 1 article reviews
    inflammatory bowel disease specific programme - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    inflammatory bowel-disease specific programme  (Adelphi Technology Inc)
    90
    Adelphi Technology Inc inflammatory bowel-disease specific programme
    Logistic regression analyses for rectal urgency in patients with ulcerative colitis. ASA = aminosalicylic acid; BMI = body mass index; CI = confidence interval; SIBDQ = Short <t>Inflammatory</t> <t>Bowel</t> <t>Disease</t> Questionnaire; UC = ulcerative colitis; OR = odds ratio; Odds ratios were computed in the regressions and, for categorical outcomes, are in comparison to the baseline reference categories: No fatigue, no abdominal pain, stool frequency (normal number of stools), no blood seen, medication use (not 5-ASA, not corticosteroid, not immunomodulators, not biologics/biosimilars).
    Inflammatory Bowel Disease Specific Programme, supplied by Adelphi Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inflammatory+bowel-disease+specific+programme/inflammatory+bowel+disease+specific+programme/pmc06964980-86-3-4
    Average 90 stars, based on 1 article reviews
    inflammatory bowel-disease specific programme - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    inflammatory bowel disease specific programmes  (Adelphi Technology Inc)
    90
    Adelphi Technology Inc inflammatory bowel disease specific programmes
    Logistic regression analyses for rectal urgency in patients with ulcerative colitis. ASA = aminosalicylic acid; BMI = body mass index; CI = confidence interval; SIBDQ = Short <t>Inflammatory</t> <t>Bowel</t> <t>Disease</t> Questionnaire; UC = ulcerative colitis; OR = odds ratio; Odds ratios were computed in the regressions and, for categorical outcomes, are in comparison to the baseline reference categories: No fatigue, no abdominal pain, stool frequency (normal number of stools), no blood seen, medication use (not 5-ASA, not corticosteroid, not immunomodulators, not biologics/biosimilars).
    Inflammatory Bowel Disease Specific Programmes, supplied by Adelphi Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inflammatory+bowel-disease+specific+programme/inflammatory+bowel+disease+specific+programme/pmc06796240-2879-6-7
    Average 90 stars, based on 1 article reviews
    inflammatory bowel disease specific programmes - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Logistic regression analyses for rectal urgency in patients with ulcerative colitis. ASA = aminosalicylic acid; BMI = body mass index; CI = confidence interval; SIBDQ = Short Inflammatory Bowel Disease Questionnaire; UC = ulcerative colitis; OR = odds ratio; Odds ratios were computed in the regressions and, for categorical outcomes, are in comparison to the baseline reference categories: No fatigue, no abdominal pain, stool frequency (normal number of stools), no blood seen, medication use (not 5-ASA, not corticosteroid, not immunomodulators, not biologics/biosimilars).

    Journal: Crohn's & Colitis 360

    Article Title: Rectal Urgency Among Patients With Ulcerative Colitis or Crohn’s Disease: Analyses from a Global Survey

    doi: 10.1093/crocol/otad052

    Figure Lengend Snippet: Logistic regression analyses for rectal urgency in patients with ulcerative colitis. ASA = aminosalicylic acid; BMI = body mass index; CI = confidence interval; SIBDQ = Short Inflammatory Bowel Disease Questionnaire; UC = ulcerative colitis; OR = odds ratio; Odds ratios were computed in the regressions and, for categorical outcomes, are in comparison to the baseline reference categories: No fatigue, no abdominal pain, stool frequency (normal number of stools), no blood seen, medication use (not 5-ASA, not corticosteroid, not immunomodulators, not biologics/biosimilars).

    Article Snippet: Data collection was undertaken by Adelphi Real-World as part of an independent survey titled the Adelphi Inflammatory Bowel Disease (IBD) Disease Specific Programme (DSP).

    Techniques: Comparison, Bioprocessing

    Logistic regression analyses for rectal urgency in patients with Crohn’s disease. ASA = aminosalicylic acid; BMI = body mass index; CD = Crohn’s disease; CDAI = Crohn’s Disease Activity Index; CI = confidence interval; SIBDQ = Short Inflammatory Bowel Disease Questionnaire; OR = odds ratio; Odds ratios were computed in the regressions and, for categorical outcomes, are in comparison to the baseline reference categories: No fatigue, no abdominal pain, stool frequency (normal number of stools), no blood seen, medication use (not 5-ASA, not corticosteroid, not immunomodulators, not biologics/biosimilars).

    Journal: Crohn's & Colitis 360

    Article Title: Rectal Urgency Among Patients With Ulcerative Colitis or Crohn’s Disease: Analyses from a Global Survey

    doi: 10.1093/crocol/otad052

    Figure Lengend Snippet: Logistic regression analyses for rectal urgency in patients with Crohn’s disease. ASA = aminosalicylic acid; BMI = body mass index; CD = Crohn’s disease; CDAI = Crohn’s Disease Activity Index; CI = confidence interval; SIBDQ = Short Inflammatory Bowel Disease Questionnaire; OR = odds ratio; Odds ratios were computed in the regressions and, for categorical outcomes, are in comparison to the baseline reference categories: No fatigue, no abdominal pain, stool frequency (normal number of stools), no blood seen, medication use (not 5-ASA, not corticosteroid, not immunomodulators, not biologics/biosimilars).

    Article Snippet: Data collection was undertaken by Adelphi Real-World as part of an independent survey titled the Adelphi Inflammatory Bowel Disease (IBD) Disease Specific Programme (DSP).

    Techniques: Activity Assay, Comparison, Bioprocessing